Co-morbidity of COVID-19 with cardio-metabolic syndromes
The severity and mortality of COVID-19 infection is positively
correlated with the co-morbidity of lung disease, diabetes,
cardiovascular diseases, and cerebrovascular diseases. A study reported
that 173 patients from 1,099 confirmed cases of COVID-19, had
co-morbidities of hypertension (23·7%), diabetes mellitus (16·2%),
heart diseases (5·8%), cerebrovascular disease (2·3%), and all of the
173 patients showed severe COVID-19
illness(Guan et al., 2020). Another
report showed that of a group of 52 COVID-19 infected patients, 32
patients died with co-morbidities of diabetes (22%) and cerebrovascular
diseases (22%)(Yang et al., 2020).
Another study reported that of 140 severe cases of COVID-19, about 30%
of the patients experienced chronic hypertension, and 12% had
diabetes(Zhang et al., 2020a).